120 related articles for article (PubMed ID: 26717601)
21. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
22. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
23. Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.
Westphal JR; Van't Hullenaar R; Geurts-Moespot A; Sweep FC; Verheijen JH; Bussemakers MM; Askaa J; Clemmensen I; Eggermont AA; Ruiter DJ; De Waal RM
Int J Cancer; 2000 Jun; 86(6):760-7. PubMed ID: 10842188
[TBL] [Abstract][Full Text] [Related]
24. Thyroid follicular cells secrete plasminogen activators and can form angiostatin from plasminogen.
Ramsden JD; Yarram S; Mathews E; Watkinson JC; Eggo MC
J Endocrinol; 2002 Jun; 173(3):475-81. PubMed ID: 12065237
[TBL] [Abstract][Full Text] [Related]
25. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure.
Basile DP; Fredrich K; Weihrauch D; Hattan N; Chilian WM
Am J Physiol Renal Physiol; 2004 May; 286(5):F893-902. PubMed ID: 15075185
[TBL] [Abstract][Full Text] [Related]
26. Surgical office-based ultrasound of the breast.
Staren ED
Am Surg; 1995 Jul; 61(7):619-26; discussion 627. PubMed ID: 7793744
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
28. [Distribution of actin isoforms in normal, dysplastic, and tumorous human breast cells].
Dugina VB; Chipysheva TA; Ermilova VD; Gabbiani D; Chaponnier C; Vasil'ev IuM
Arkh Patol; 2008; 70(2):28-31. PubMed ID: 18540438
[TBL] [Abstract][Full Text] [Related]
29. Anti-angiogenic role of angiostatin during corneal wound healing.
Gabison E; Chang JH; Hernández-Quintela E; Javier J; Lu PC; Ye H; Kure T; Kato T; Azar DT
Exp Eye Res; 2004 Mar; 78(3):579-89. PubMed ID: 15106938
[TBL] [Abstract][Full Text] [Related]
30. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
[TBL] [Abstract][Full Text] [Related]
31. Angiostatin binds ATP synthase on the surface of human endothelial cells.
Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
[TBL] [Abstract][Full Text] [Related]
32. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.
Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA
Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S; Palmer K; Gauldie J
Am J Pathol; 2001 Sep; 159(3):1137-47. PubMed ID: 11549607
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of angiostatin in effusions from patients with malignant disease.
Rotenberg RG; Rozas NS; Guerri L; Cher ML; Gamboni M; Lema N; Bonfil RD
Oncol Rep; 2004 Feb; 11(2):523-8. PubMed ID: 14719094
[TBL] [Abstract][Full Text] [Related]
35. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease.
Matsunaga T; Chilian WM; March K
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2042-6. PubMed ID: 15840902
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta 1 inhibits generation of angiostatin by human pancreatic cancer cells.
O'Mahony CA; Albo D; Tuszynski GP; Berger DH
Surgery; 1998 Aug; 124(2):388-93. PubMed ID: 9706163
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer.
Wang ZH; Gong JL; Yu M; Yang H; Lai JH; Ma MX; Wu H; Li L; Tan DY
Asian Pac J Cancer Prev; 2011; 12(8):1973-7. PubMed ID: 22292636
[TBL] [Abstract][Full Text] [Related]
39. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
40. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
